Northrop Grumman reported third quarter 2026 sales of $11.1 billion, up 7% from $10.4 billion a year earlier, and diluted earnings per share of $7.89 versus $7.67. The company raised its 2026 guidance for sales, segment operating income and MTM-adjusted EPS, while operating margin rate declined to 11.4% from 11.9%.
Q3 2026 sales rose 7% to $11.1 billion; net earnings were $1.1 billion, or $7.89 per diluted share, versus $7.67 a year earlier
2026 MTM-adjusted EPS guidance raised to $29.35 to $29.75 from $28.60 to $29.10; sales guidance is $43.75 billion to $44.25 billion
Backlog reached $109.6 billion at September 30, 2026, up 15% from $95.7 billion at December 31, 2025; net awards were $16.4 billion in the quarter
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Northrop Grumman's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$41.95B
+2.2%
$29.08
+2.6%
10.0%
FY2024
$41.03B
+4.4%
$28.34
+109.5%
10.2%
FY2023
$39.29B
+7.3%
$13.53
-57.0%
5.2%
FY2022
$36.60B
+2.6%
$31.47
-27.7%
13.4%
FY2021
$35.67B
-3.1%
$43.54
+128.8%
19.6%
Frequently asked questions
When is Northrop Grumman's next earnings date?
Northrop Grumman has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Northrop Grumman earn last quarter?
For the quarter ended Sep 2026, Northrop Grumman reported diluted EPS of $7.89 (+2.9% year over year) on revenue of $11.12B (+6.7%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.